icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research icrowd research

Digital Diagnostics Market Survey Detailed Analysis and Forecast 2024-2031

Mar 27, 2024 1:00 PM ET

Digital Diagnostics Market Survey Detailed Analysis and Forecast 2024-2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on theGlobal Digital Diagnostics Market Size, Share & Trends Analysis Report By Application (Cardiology, Oncology, Neurology, Pathology), End-User (Hospitals, Clinical Laboratories), And Product (Hardware And Software), Region, Market Outlook And Industry Analysis 2031″

Digital Diagnostics Market Size is valued at USD 1.66 billion in 2023 and is predicted to reach USD 6.32 billion by the year 2031 at a 18.48% CAGR during the forecast period for 2024-2031.


Get A Free Report Brochure::


Digital Diagnostics Market Report Scope:

Report Attribute


Market Size Value In 2023

USD 1.66 Bn

Revenue Forecast In 2031

USD 6.32 Bn

Growth Rate CAGR

CAGR of 18.48% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year


Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product, Application, and End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea


Digital technologies are applied to healthcare diagnostics to change the way diseases are identified, tracked, and treated. This process is known as digital diagnostics. Digital diagnostics offer a more accurate and practical approach to healthcare diagnostics, lowering mistakes, improving accuracy, and enabling early treatments by utilizing data analytics, Al algorithms, and remote patient monitoring.

Digital diagnostics has the potential to enhance test accessibility by overcoming limitations associated with operating hours and personnel availability, which are factors that impede traditional diagnostics.

It can also increase access to diagnostics in low-resource settings, which is more prevalent in high-income, middle-income, and low-income countries, where inadequate infrastructure and medical personnel pose an additional obstacle. Patients may acquire access to superior health information, develop the ability to self-manage their health, ensure adherence to medical treatment, and embrace healthier lifestyles by utilizing digital diagnostics.


The growing use of digital health technologies, growing healthcare expenditures, and the demand for precise and readily available diagnostic solutions are all expected to propel the digital diagnostics market’s rise in the upcoming years. Long-standing competitors and recent arrivals can benefit significantly from this market’s chances to take advantage of the rising need for cutting-edge diagnostic technology.


List of Prominent Players in the Digital Diagnostics Market:

  • Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • GE Healthcare
  • Siemens Healthineers
  • Medtronic plc
  • Nano-X Imaging Ltd.
  • Koninklijke Philips N.V.
  • Digital Diagnostics Inc.
  • Riverain Technologies
  • VUNO, Inc.
  • AliveCor, Inc.
  • ai.
  • Brainomix
  • io
  • Canon Inc.


Market Dynamics:


Heart disease, diabetes, and cancer are typical chronic illnesses that cause substantial concerns for the world’s healthcare systems. Using digital diagnostics to treat chronic diseases has several benefits.

Wearable technology, at-home testing, and remote monitoring can assist with early detection, enabling earlier intervention and reducing the disease burden. Furthermore, electronic diagnostics provide ongoing patient health data monitoring, allowing for more effective sickness treatment and customized drug adjustments.


Order this Premium Report:



One major issue is that patients and healthcare professionals need to be made aware of digital diagnostics. Digital diagnostic technology may not be widely used since a number of healthcare professionals may not be aware of its potential and advantages. Similarly, patients might not be aware of the benefits and accessibility of the tools. This ignorance could hinder the use of digital diagnostics and restrict the growth of the sector.


Regional Trends:

The North American digital diagnostics market is expected to register a significant market share in revenue and is projected to develop at a high CAGR soon. The expanding use of cutting-edge technologies, rising investments from both public and private entities, and rising product launches and initiatives by significant market players are all factors contributing to the expansion of the market in the region. For instance, PathAI announced the release of its AISightTM digital pathology image management system (IMS) for pathology laboratories in August 2023.

This will additionally offer effective, comprehensive digital pathology workflows. Besides, Asia Pacific had a substantial share of the market. The rising prices of computer-aided diagnostics in the Asia-Pacific healthcare region are among the causes driving this growth. Growing awareness of these technologies’ advantages contributes to developing the digital diagnostics market in Asia-Pacific.


Recent Developments:

  • In Feb 2024, Roche disclosed that it had signed an arrangement with PathAI. PathAI will collaborate exclusively with Roche Tissue Diagnostics (RTD) to develop AI-enabled digital pathology algorithms in the companion diagnostics market, according to the conditions of the agreement. RTD will collaborate exclusively with PathAI for a set period as the sole external algorithm development business for AI-powered companion diagnostics while keeping the opportunity to create its own algorithms for companion diagnostics. PathAI will retain the freedom to develop algorithms outside of companion diagnostics.
  • In May 2022: In its most recent round of funding, the MedTech startup TestCard raised $10 million, which it will broadly use to expand the market for its current product line and introduce new offerings, including flu, pregnancy, CKD, and diabetes tests.
  • In February 2022: In order to enable customers to request tests and potentially collect samples from home, Labcorp introduced Labcorp OnDemand, an online platform. The best diagnostic tests will be more easily accessible to people due to this platform.


Get Specific Chapter/Information From The Report:


Segmentation of Digital Diagnostics Market-

By Product-

  • Hardware
  • Software

By Application-

  • Cardiology
  • Oncology
  • Neurology
  • Pathology
  • Others

By End-User-

  • Hospitals
  • Clinical Laboratories
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Details insights on this market:    


Why should buy this report:

  • To receive a comprehensive analysis of the prospects for global Digital Diagnostics market
  • To receive industry overview and future trends of global Digital Diagnostics market
  • To analyze the Digital Diagnostics market drivers and challenges
  • To get information on the Digital Diagnostics market size value (US$ Mn) forecast till 2031
  • Major Investments, Mergers & Acquisition in global Digital Diagnostics market industry


Other Related Reports Published by InsightAce Analytic:

AI-Based Digital Pathology Solutions Market

Smart or AI In-Vitro Diagnostics Market

Virtual Diagnostic Market

Digital Health Market

Cardiac AI Monitoring and Diagnostics Market


About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.


Contact US:

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: [email protected]
Site Visit:
Follow Us on LinkedIn @

Tags: , , , , , , , , , ,

See Campaign:

Contact Information:

Corporate Office : Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028 loaction icon Sales Office (U.S.) : 344 Grove St Unit #967 Jersey City, NJ 07302 email [email protected] call icon North America: +1 551 226 6109 Asia: +91 79 72967118


BNN, Extended Distribution, Go Media, iCN Internal Distribution, IPS, Research Newswire, English